Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 341

    1.

    Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

    Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB.

    Diabetes Care. 2004 Aug;27(8):1991-7.PMID: 15277429 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

    Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

    Circulation. 2005 Nov 29;112(22):3375-83.PMID: 16316964 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.

    Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R, Hu FB.

    Diabetologia. 2004 Dec;47(12):2129-36. Epub 2004 Dec 15.PMID: 15662553 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.

    Bruno G, Merletti F, Biggeri A, Bargero G, Prina-Cerai S, Pagano G, Cavallo-Perin P.

    Diabetologia. 2006 May;49(5):937-44. Epub 2006 Mar 9.PMID: 16525840 [PubMed - indexed for MEDLINE]Related articles

    5.

    Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

    Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE.

    JAMA. 2005 Jul 20;294(3):326-33.PMID: 16030277 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.

    Li TY, Brennan AM, Wedick NM, Mantzoros C, Rifai N, Hu FB.

    J Nutr. 2009 Jul;139(7):1333-8. Epub 2009 May 6.PMID: 19420347 [PubMed - indexed for MEDLINE]Related articles

    7.

    Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study.

    Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV.

    Diabetes Care. 2003 Jan;26(1):16-23.PMID: 12502653 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.

    Martin SS, Qasim AN, Mehta NN, Wolfe M, Terembula K, Schwartz S, Iqbal N, Schutta M, Bagheri R, Reilly MP.

    Diabetes. 2009 Aug;58(8):1887-92. Epub 2009 Jun 2.PMID: 19491209 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    C-reactive protein and incident cardiovascular events among men with diabetes.

    Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB.

    Diabetes Care. 2004 Apr;27(4):889-94.PMID: 15047644 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

    Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.

    JAMA. 2007 Aug 15;298(7):776-85.PMID: 17699011 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.

    Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM.

    Diabetes Care. 2005 Aug;28(8):1916-21.PMID: 16043732 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.

    Wägner AM, Pérez A, Calvo F, Bonet R, Castellví A, Ordóñez J.

    Diabetes Care. 1999 May;22(5):812-7.PMID: 10332687 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).

    Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN.

    Diabetologia. 2009 Feb;52(2):218-25. Epub 2008 Oct 30. Erratum in: Diabetologia. 2009 Mar;52(3):556. PMID: 18972097 [PubMed - indexed for MEDLINE]Related articles

    14.

    Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study.

    Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET.

    Diabetes Care. 1998 Aug;21(8):1258-65.PMID: 9702430 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.

    Hadaegh F, Harati H, Ghanbarian A, Azizi F.

    Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):571-7.PMID: 16874147 [PubMed - indexed for MEDLINE]Related articles

    16.

    Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia.

    Gimeno-Orna JA, Faure-Nogueras E, Sancho-Serrano MA.

    Diabet Med. 2005 Jan;22(1):26-31.PMID: 15606687 [PubMed - indexed for MEDLINE]Related articles

    17.

    Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

    Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group.

    Circulation. 2001 Sep 4;104(10):1108-13.PMID: 11535564 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.

    Hu D, Jablonski KA, Sparling YH, Robbins DC, Lee ET, Welty TK, Howard BV.

    Ann Epidemiol. 2002 Feb;12(2):79-85.PMID: 11880214 [PubMed - indexed for MEDLINE]Related articles

    19.

    The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

    Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.

    Clin Chem Lab Med. 2004;42(12):1355-63.PMID: 15576296 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.

    Wei M, Gaskill SP, Haffner SM, Stern MP.

    Diabetes Care. 1998 Jul;21(7):1167-72.PMID: 9653614 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data